Eli Lilly Aktie 947556 / US5324571083
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
30.10.2025 11:57:30
|
Eli Lilly And Co. Q3 Profit Increases, Beats Estimates
(RTTNews) - Eli Lilly And Co. (LLY) revealed earnings for its third quarter that Increased from last year and beat the Street estimates.
The company's bottom line came in at $5.582 billion, or $6.21 per share. This compares with $970.3 million, or $1.07 per share, last year.
Excluding items, Eli Lilly And Co. reported adjusted earnings of $6.311 billion or $7.02 per share for the period.
Analysts on average had expected the company to earn $5.89 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 53.9% to $17.600 billion from $11.439 billion last year.
Eli Lilly And Co. earnings at a glance (GAAP) :
-Earnings: $5.582 Bln. vs. $970.3 Mln. last year. -EPS: $6.21 vs. $1.07 last year. -Revenue: $17.600 Bln vs. $11.439 Bln last year.
-Guidance: Full year EPS guidance: $23.00 to $23.70 Full year revenue guidance: $63.0 to $63.5 Bln
